Genvec (FRA:GVC2) COGS-to-Revenue : 0.00 (As of Mar. 2017)

View and export this data going back to . Start your Free Trial

What is Genvec COGS-to-Revenue?

Genvec's Cost of Goods Sold for the three months ended in Mar. 2017 was €0.00 Mil. Its Revenue for the three months ended in Mar. 2017 was €0.11 Mil.

Genvec's COGS to Revenue for the three months ended in Mar. 2017 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Genvec's Gross Margin % for the three months ended in Mar. 2017 was N/A%.

Genvec COGS-to-Revenue Historical Data

The historical data trend for Genvec's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genvec COGS-to-Revenue Chart

Genvec Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

COGS-to-Revenue

Get a 7-Day Free Trial

Genvec Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Genvec COGS-to-Revenue Calculation

Genvec's COGS to Revenue for the fiscal year that ended in Dec. 2016 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.484
	=	0.00

Genvec's COGS to Revenue for the quarter that ended in Mar. 2017 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.107
	=	0.00

Genvec (FRA:GVC2) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Genvec's Gross Margin % for the three months ended in Mar. 2017 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0.107
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Genvec COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genvec's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genvec (FRA:GVC2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genvec Inc (FRA:GVC2) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.genvec.com

Genvec Inc was incorporated under the laws of the state of Delaware on December 7, 1992.The Company is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. Its development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus or RSV, herpes simplex virus or HSV, and malaria. In the area of animal health the Company is developing vaccines against foot-and-mouth disease or FMD. In collaboration with Novartis, the Companys hearing and balance disorders program is focused on the restoration of hearing and balance function through the regeneration of critical cells of the inner ear. The Company is currently developing preventative vaccines, against RSV and malaria and therapeutic vaccine against HSV.

Genvec (FRA:GVC2) Headlines

No Headlines